177 related articles for article (PubMed ID: 10052993)
1. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies.
Li ZJ; Zell MT; Munson EJ; Grant DJ
J Pharm Sci; 1999 Mar; 88(3):337-46. PubMed ID: 10052993
[TBL] [Abstract][Full Text] [Related]
2. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
Wang X; Wang XJ; Ching CB
Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
Huang J; Chen S; Guzei IA; Yu L
J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
[TBL] [Abstract][Full Text] [Related]
4. The importance of screening solid-state phases of a racemic modification of a chiral drug: thermodynamic and structural characterization of solid-state phases of etiracetam.
Herman C; Vermylen V; Norberg B; Wouters J; Leyssens T
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2013 Aug; 69(Pt 4):371-8. PubMed ID: 23873062
[TBL] [Abstract][Full Text] [Related]
5. Study of the characterization and crystallization of 4-hydroxy-2-pyrrolidone.
Wang XJ; Wiehler H; Ching CB
Chirality; 2004 May; 16(4):220-7. PubMed ID: 15034904
[TBL] [Abstract][Full Text] [Related]
6. Phase diagram of (R)- and (S)-4-hydroxy-2-pyrrolidone mixtures: a new case of a conglomerate-forming system.
Di Silvestro G; Palmisano G; Pellegata R
J Pharm Sci; 1993 Jul; 82(7):758-60. PubMed ID: 8360853
[TBL] [Abstract][Full Text] [Related]
7. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
[TBL] [Abstract][Full Text] [Related]
8. Three different types of chirality-driven crystallization within the series of uniformly substituted phenyl glycerol ethers.
Bredikhin AA; Bredikhina ZA; Novikova VG; Pashagin AV; Zakharychev DV; Gubaidullin AT
Chirality; 2008 Nov; 20(10):1092-103. PubMed ID: 18767134
[TBL] [Abstract][Full Text] [Related]
9. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.
Duddu SP; Grant DJ
Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382
[TBL] [Abstract][Full Text] [Related]
10. Solid tryptophan as a pseudoracemate: physicochemical and crystallographic characterization.
Li Y; Zhao Y; Zhang Y
Chirality; 2015 Jan; 27(1):88-94. PubMed ID: 25354341
[TBL] [Abstract][Full Text] [Related]
11. The binary phase diagram of propranolol hydrochloride and crystallization-based enantioseparation.
Polenske D; Lorenz H; Seidel-Morgenstern A
J Pharm Sci; 2010 Apr; 99(4):1762-73. PubMed ID: 19798754
[TBL] [Abstract][Full Text] [Related]
12. Thermodynamic and structural aspects of sulfonamide crystals and solutions.
Perlovich GL; Tkachev VV; Strakhova NN; Kazachenko VP; Volkova TV; Surov OV; Schaper KJ; Raevsky OA
J Pharm Sci; 2009 Dec; 98(12):4738-55. PubMed ID: 19408296
[TBL] [Abstract][Full Text] [Related]
13. Racemic species of sodium ibuprofen: characterization and polymorphic relationships.
Zhang GG; Paspal SY; Suryanarayanan R; Grant DJ
J Pharm Sci; 2003 Jul; 92(7):1356-66. PubMed ID: 12820140
[TBL] [Abstract][Full Text] [Related]
14. Solubility properties of racemic praziquantel and its enantiomers.
el-Arini SK; Giron D; Leuenberger H
Pharm Dev Technol; 1998 Nov; 3(4):557-64. PubMed ID: 9834959
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling study of chiral drug crystals: lattice energy calculations.
Li ZJ; Ojala WH; Grant DJ
J Pharm Sci; 2001 Oct; 90(10):1523-39. PubMed ID: 11745711
[TBL] [Abstract][Full Text] [Related]
16. Structural Aspects of Solid Solutions of Enantiomers.
Brandel C; Petit S; Cartigny Y; Coquerel G
Curr Pharm Des; 2016; 22(32):4929-4941. PubMed ID: 27510486
[TBL] [Abstract][Full Text] [Related]
17. Multiple approaches to pharmaceutical polymorphism investigation--a case study.
Li H; Kiang YH; Jona J
Eur J Pharm Sci; 2009 Dec; 38(5):426-32. PubMed ID: 19748574
[TBL] [Abstract][Full Text] [Related]
18. Effect of molecular chirality on racemate stability: alpha-amino acids with nonpolar R groups.
Huang J; Yu L
J Am Chem Soc; 2006 Feb; 128(6):1873-8. PubMed ID: 16464087
[TBL] [Abstract][Full Text] [Related]
19. Formation of solid solutions between racemic and enantiomeric citalopram oxalate.
de Diego HL; Bond AD; Dancer RJ
Chirality; 2011 May; 23(5):408-16. PubMed ID: 21472783
[TBL] [Abstract][Full Text] [Related]
20. Effects of configuration around the chiral carbon atoms on the crystal properties of ephedrinium and pseudoephedrinium salicylates.
Duddu SP; Grant DJ
Pharm Res; 1994 Nov; 11(11):1549-56. PubMed ID: 7870670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
